Status:
UNKNOWN
The Effect of Carnitine Supplementation on Cardiac Function and Lipid Profile in Patients With Drug Resistant Epilepsy on Ketogenic Diet
Lead Sponsor:
Ain Shams University
Conditions:
l Carnitine With Ketogenic Diet
Eligibility:
All Genders
1-16 years
Phase:
EARLY_PHASE1
Brief Summary
Primary aim: Demonstrating the effect of carnitine supplementation on lipid profile and cardiovascular functions in patients with DRE on KD. Secondary aim: To highlight the effect of carnitine supple...
Detailed Description
The KD, a strict diet high in fat and low in carbohydrates, increases the ketone body concentrations that could lead to an enhancement of inhibitory neurotransmission and thereby possibly reducing the...
Eligibility Criteria
Inclusion
- \- All aged from 1 month till 16 years old with DRE on KD.
Exclusion
- Patients who are already on KD and carnitine supplements.
Key Trial Info
Start Date :
January 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT06198803
Start Date
January 3 2022
End Date
July 1 2024
Last Update
January 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo
Cairo, Egypt